Dysplasia as a predictive marker for invasive carcinoma in barrett esophagus: A follow-up study based on 138 cases from a diagnostic variability study

Human Pathology

Volumn 32, Issue 4, 2001, Pages 379-388

  Montgomery, Elizabeth ^a   Goldblum, John R ^a   Greenson, Joel K ^a   Haber, Marian M ^a   Lamps, Laura W ^a   Lauwers, Gregory Y ^a   Lazenby, Audrey J ^a   Lewin, David N ^a   Robert, Marie E ^a   Washington, Kay ^a   Zahurak, Marianna L ^a   Hart, John ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Barrett adenocarcinoma; Barrett esophagus; Dysplasia; Grading; Prognostic markers

Indexed keywords

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; BENIGN TUMOR; CANCER DIAGNOSIS; CHILD; DIFFERENTIAL DIAGNOSIS; DYSPLASIA; ENDOSCOPIC BIOPSY; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PREDICTION; STATISTICAL ANALYSIS; SURVIVAL; TUMOR BIOPSY;

EID: 0035034648     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2001.23511     Document Type: Article

References (39)

1. Increased expression of the cyclin D1 gene in Barrett's esophagus
2. Molecular analysis of the TP53 gene in Barrett's adenocarcinoma
3. Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus
4. Evolution of neoplastic cell lineages in Barrett oesophagus
5. 17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma
6. Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma
7. p53 gene mutations in Barrett's epithelium and esophageal cancer
8. Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancer
9. p53 protein expression in Barrett's adenocarcinoma: A frequent event with no prognostic significance
10. Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: Pathological and prognostic correlations
11. Barrett's mucosa. From metaplasia . . . to cancer
12. 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus
13. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue
14. Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus
15. Cellular kinetics in Barrett's epithelium carcinogenic sequence: Roles of apoptosis, bcl-2 protein, and cellular proliferation
16. Barrett esophagus with dysplasia. Flow cytometric DNA analysis of routine, paraffin-embedded mucosal biopsies
17. p53-mutant clones and field effects in Barrett's esophagus
18. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma
19. Progression to cancer in Barrett's esophagus is associated with genomic instability
20. Barrett's esophagus: Ordering the events that lead to cancer
21. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas
22. Barrett's esophagus. The significance of p53 in clinical practice
23. Rising incidence of adenocarcinoma of the esophagus and gastric cardia
24. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
25. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus
26. Barrett's esophagus: Does the incidence of adenocarcinoma matter?
27. Observer variation in the diagnosis of dysplasia in Barrett's esophagus
28. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmation
29. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma
30. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus
31. Nonparametric estimation from incomplete observations
32. Statistical aspects of the analysis of data from retrospective studies of disease
33. Regression models and life-tables (with discussion)
34. Barrett's oesophagus
35. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications
36. Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative
37. Cancer surveillance in ulcerative colitis